Skip to main content
Erschienen in: World Journal of Urology 8/2021

20.01.2021 | Original Article

Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries

verfasst von: Kevin A. Nguyen, Danny Q. Le, Yvonne T. Bui, Sonali D. Advani, Joseph Renzulli II, Patrick A. Kenney, Michael S. Leapman

Erschienen in: World Journal of Urology | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the incidence, risk factors, and clinical outcomes associated with (Clostridioides difficile infection) CDI following urological surgery, which is the leading cause of nosocomial diarrhea and a growing public health burden.

Methods

We queried the National Surgical Quality Improvement Program (NSQIP) to identify patients undergoing urological surgery in 2015–2016. We evaluated the 30-day incidence and factors associated with postoperative CDI and 30-day hospital readmission and length of stay as secondary outcomes. Among the subset of patients undergoing radical cystectomy with urinary diversion (surgery with highest CDI incidence) we used multivariable logistic regression analysis to evaluate independent clinical and demographic factors associated with postoperative CDI.

Results

We identified 98,463 patients during the study period. The overall 30-day incidence of CDI was 0.31%, but varied considerably across surgery type. The risk of CDI was greatest following radical cystectomy with urinary diversion (2.72%) compared to all other urologic procedures (0.19%) and was associated with increased risk of hospital readmission (p < 0.0001), re-operation (p < 0.0001), and longer mean length of stay (p < 0.0001) in this cohort. Among patients undergoing radical cystectomy with urinary diversion, multivariable logistic regression revealed that preoperative renal failure (OR: 5.30, 95% CI 1.13–24.9, p = 0.035) and blood loss requiring transfusion (OR: 1.67, 95% CI 1.15–2.44, p = 0.0075) were independently associated with CDI.

Conclusions

In a nationally representative cohort, the incidence of CDI was low but varied substantially across surgery types. CDI was most common following radical cystectomy and associated with potentially modifiable factors such as blood transfusion and significantly longer length of stay.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Khanna S, Pardi DS (2012) Clostridium difficile infection: new insights into management. Mayo Clin Proc 87:1106–1117CrossRef Khanna S, Pardi DS (2012) Clostridium difficile infection: new insights into management. Mayo Clin Proc 87:1106–1117CrossRef
2.
Zurück zum Zitat Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ (2016) Clostridium difficile infection. Nat Rev Dis Primers 2:16020CrossRef Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ (2016) Clostridium difficile infection. Nat Rev Dis Primers 2:16020CrossRef
3.
4.
Zurück zum Zitat Suljagic V, Miljkovic I, Starcevic S, Stepic N, Kostic Z, Jovanovic D et al (2017) Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control study. Antimicrob Resist Infect Control 6:31CrossRef Suljagic V, Miljkovic I, Starcevic S, Stepic N, Kostic Z, Jovanovic D et al (2017) Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control study. Antimicrob Resist Infect Control 6:31CrossRef
5.
Zurück zum Zitat Yoo SJ (2010) The risk factors of Clostridium difficile colitis in colorectal surgery. J Korean Soc Coloproctol 26:307–308CrossRef Yoo SJ (2010) The risk factors of Clostridium difficile colitis in colorectal surgery. J Korean Soc Coloproctol 26:307–308CrossRef
6.
Zurück zum Zitat Rodrigues MA, Brady RR, Rodrigues J, Graham C, Gibb AP (2010) Clostridium difficile infection in general surgery patients; identification of high-risk populations. Int J Surg (Lond Engl) 8:368–372CrossRef Rodrigues MA, Brady RR, Rodrigues J, Graham C, Gibb AP (2010) Clostridium difficile infection in general surgery patients; identification of high-risk populations. Int J Surg (Lond Engl) 8:368–372CrossRef
7.
Zurück zum Zitat Abdelsattar ZM, Krapohl G, Alrahmani L, Banerjee M, Krell RW, Wong SL et al (2015) Postoperative burden of hospital-acquired Clostridium difficile infection. Infect Control Hosp Epidemiol 36:40–46CrossRef Abdelsattar ZM, Krapohl G, Alrahmani L, Banerjee M, Krell RW, Wong SL et al (2015) Postoperative burden of hospital-acquired Clostridium difficile infection. Infect Control Hosp Epidemiol 36:40–46CrossRef
8.
Zurück zum Zitat Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH (2016) Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis 16:447CrossRef Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH (2016) Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis 16:447CrossRef
9.
Zurück zum Zitat Cotter KJ, Fan Y, Sieger GK, Weight CJ, Konety BR (2017) Prevalence of Clostridium Difficile infection in patients after radical cystectomy and neoadjuvant chemotherapy. Bladd Cancer (Amst Neth) 3:305–310CrossRef Cotter KJ, Fan Y, Sieger GK, Weight CJ, Konety BR (2017) Prevalence of Clostridium Difficile infection in patients after radical cystectomy and neoadjuvant chemotherapy. Bladd Cancer (Amst Neth) 3:305–310CrossRef
10.
Zurück zum Zitat Liu NW, Shatagopam K, Monn MF, Kaimakliotis HZ, Cary C, Boris RS et al (2015) Risk for Clostridium difficile infection after radical cystectomy for bladder cancer: analysis of a contemporary series. Urol Oncol 33(503):e17-22 Liu NW, Shatagopam K, Monn MF, Kaimakliotis HZ, Cary C, Boris RS et al (2015) Risk for Clostridium difficile infection after radical cystectomy for bladder cancer: analysis of a contemporary series. Urol Oncol 33(503):e17-22
11.
Zurück zum Zitat Carignan A, Allard C, Pepin J, Cossette B, Nault V, Valiquette L (2008) Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis Off Publ Infect Dis Soc Am 46:1838–1843CrossRef Carignan A, Allard C, Pepin J, Cossette B, Nault V, Valiquette L (2008) Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis Off Publ Infect Dis Soc Am 46:1838–1843CrossRef
12.
Zurück zum Zitat McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE et al (2018) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA). Clin Infect Dis 66:e1–e48CrossRef McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE et al (2018) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA). Clin Infect Dis 66:e1–e48CrossRef
13.
Zurück zum Zitat Chiang SR, Lai CC, Ho CH, Chen CM, Chao CM, Wang JJ et al (2018) Prolonged mechanical ventilation assistance interacts synergistically with carbapenem for clostridium difficile infection in critically Ill patients. J Clin Med 7(8):224CrossRef Chiang SR, Lai CC, Ho CH, Chen CM, Chao CM, Wang JJ et al (2018) Prolonged mechanical ventilation assistance interacts synergistically with carbapenem for clostridium difficile infection in critically Ill patients. J Clin Med 7(8):224CrossRef
14.
Zurück zum Zitat Rogers MA, Micic D, Blumberg N, Young VB, Aronoff DM (2014) Storage duration of red blood cell transfusion and Clostridium difficile infection: a within person comparison. PLoS ONE 9:e89332CrossRef Rogers MA, Micic D, Blumberg N, Young VB, Aronoff DM (2014) Storage duration of red blood cell transfusion and Clostridium difficile infection: a within person comparison. PLoS ONE 9:e89332CrossRef
15.
Zurück zum Zitat Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, Croucher N et al (2009) Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun 77:3661–3669CrossRef Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, Croucher N et al (2009) Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun 77:3661–3669CrossRef
16.
Zurück zum Zitat Asempa TE, Nicolau DP (2017) Clostridium difficile infection in the elderly: an update on management. Clin Interv Aging 12:1799–1809CrossRef Asempa TE, Nicolau DP (2017) Clostridium difficile infection in the elderly: an update on management. Clin Interv Aging 12:1799–1809CrossRef
17.
Zurück zum Zitat Rajashekar A, Perazella MA, Crowley S (2008) Systemic diseases with renal manifestations. Prim Care 35(297–328):vi–vii Rajashekar A, Perazella MA, Crowley S (2008) Systemic diseases with renal manifestations. Prim Care 35(297–328):vi–vii
18.
Zurück zum Zitat Koenig SM, Truwit JD (2006) Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 19:637–657CrossRef Koenig SM, Truwit JD (2006) Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 19:637–657CrossRef
19.
Zurück zum Zitat Kim JL, Park JH, Han SB, Cho IY, Jang KM (2017) Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis. J Arthroplasty 32:320–325CrossRef Kim JL, Park JH, Han SB, Cho IY, Jang KM (2017) Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis. J Arthroplasty 32:320–325CrossRef
20.
Zurück zum Zitat Kaneko K, Kawai K, Tsuno NH, Ishihara S, Yamaguchi H, Sunami E et al (2015) Perioperative allogeneic blood transfusion is associated with surgical site infection after abdominoperineal resection-a space for the implementation of patient blood management strategies. Int Surg 100:797–804CrossRef Kaneko K, Kawai K, Tsuno NH, Ishihara S, Yamaguchi H, Sunami E et al (2015) Perioperative allogeneic blood transfusion is associated with surgical site infection after abdominoperineal resection-a space for the implementation of patient blood management strategies. Int Surg 100:797–804CrossRef
21.
Zurück zum Zitat Shander A, Javidroozi M, Perelman S, Puzio T, Lobel G (2012) From bloodless surgery to patient blood management. Mt Sinai J Med 79:56–65CrossRef Shander A, Javidroozi M, Perelman S, Puzio T, Lobel G (2012) From bloodless surgery to patient blood management. Mt Sinai J Med 79:56–65CrossRef
22.
Zurück zum Zitat Tyson MD, Castle EP, Humphreys MR, Andrews PE (2014) Venous thromboembolism after urological surgery. J Urol 192:793–797CrossRef Tyson MD, Castle EP, Humphreys MR, Andrews PE (2014) Venous thromboembolism after urological surgery. J Urol 192:793–797CrossRef
23.
Zurück zum Zitat Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379–1390CrossRef Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379–1390CrossRef
24.
Zurück zum Zitat Bonkat G, Bartoletti R, Bruyére F, Cai T, Geerlings SE, Köves B et al (2020) EAU guidelines on urological infections 2020. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam the Netherlands 2020. ISBN 978-94-92671-07-3 Bonkat G, Bartoletti R, Bruyére F, Cai T, Geerlings SE, Köves B et al (2020) EAU guidelines on urological infections 2020. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam the Netherlands 2020. ISBN 978-94-92671-07-3
25.
Zurück zum Zitat Slimings C, Riley TV (2014) Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemotherap 69:881–891CrossRef Slimings C, Riley TV (2014) Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemotherap 69:881–891CrossRef
27.
Zurück zum Zitat Tschudin-Sutter S, Braissant O, Erb S, Stranden A, Bonkat G, Frei R et al (2016) Growth patterns of Clostridium difficile: correlations with strains, binary toxin and disease severity: a prospective cohort study. PLoS ONE 11:e0161711CrossRef Tschudin-Sutter S, Braissant O, Erb S, Stranden A, Bonkat G, Frei R et al (2016) Growth patterns of Clostridium difficile: correlations with strains, binary toxin and disease severity: a prospective cohort study. PLoS ONE 11:e0161711CrossRef
28.
Zurück zum Zitat Banaei N, Anikst V, Schroeder LF (2015) Burden of Clostridium difficile infection in the United States. New Engl J Med 372:2368–2369CrossRef Banaei N, Anikst V, Schroeder LF (2015) Burden of Clostridium difficile infection in the United States. New Engl J Med 372:2368–2369CrossRef
29.
Zurück zum Zitat Parker WP, Tollefson MK, Heins CN, Hanson KT, Habermann EB, Zaid HB et al (2016) Characterization of perioperative infection risk among patients undergoing radical cystectomy: results from the national surgical quality improvement program. Urol Oncol 34:532.e13-e19CrossRef Parker WP, Tollefson MK, Heins CN, Hanson KT, Habermann EB, Zaid HB et al (2016) Characterization of perioperative infection risk among patients undergoing radical cystectomy: results from the national surgical quality improvement program. Urol Oncol 34:532.e13-e19CrossRef
30.
Zurück zum Zitat Li X, Wilson M, Nylander W, Smith T, Lynn M, Gunnar W (2016) Analysis of morbidity and mortality outcomes in postoperative Clostridium Difficile infection in the veterans health administration. JAMA Surg 151:314–322CrossRef Li X, Wilson M, Nylander W, Smith T, Lynn M, Gunnar W (2016) Analysis of morbidity and mortality outcomes in postoperative Clostridium Difficile infection in the veterans health administration. JAMA Surg 151:314–322CrossRef
31.
Zurück zum Zitat Weiss A, Anderson JE, Chang DC (2015) Comparing the national surgical quality improvement program with the nationwide inpatient sample database. JAMA Surg 150:815–816CrossRef Weiss A, Anderson JE, Chang DC (2015) Comparing the national surgical quality improvement program with the nationwide inpatient sample database. JAMA Surg 150:815–816CrossRef
Metadaten
Titel
Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries
verfasst von
Kevin A. Nguyen
Danny Q. Le
Yvonne T. Bui
Sonali D. Advani
Joseph Renzulli II
Patrick A. Kenney
Michael S. Leapman
Publikationsdatum
20.01.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 8/2021
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-020-03551-y

Weitere Artikel der Ausgabe 8/2021

World Journal of Urology 8/2021 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.